エチオピア中部における結核患者における抗結核薬による肝損傷
Zelalem Petros1,2, Anteneh Tamirat3, Wondimu Assefa4
1Department of Pharmacy, College of Medicine and Health Sciences, Wachemo University, Hosaina, Ethiopia. zelalemp@yahoo.com.
Scientific reports
|August 25, 2025
まとめ
エチオピアでの研究では,結核患者の16.0%が抗結核薬による肝損傷 (ATDILI) を発症した. 女性性別,年長,低BMI,HIV陽性性は,ATDILIの有意な予測要因でした.
科学分野:
- ヘパトロジー
- 感染症
- 薬用警戒について
背景:
- 抗結核薬による結核治療は死亡率を大幅に低下させる.
- しかし,抗結核薬は肝臓損傷 (ATDILI) を引き起こし,薬剤耐性などの合併症を増加させる可能性があります.
- ATDILIの流行と予測因子に関するデータは限られている.
研究 の 目的:
- 中央エチオピアのホサナ市で結核患者の間でATDILIの流行を評価する.
- ATDILIに関連する予測要因と臨床的特徴を特定する.
- 結核患者のATDILIのモニタリング戦略を参考にする.
主な方法:
- 前向きなコホート研究で,新たに結核と診断され,第一線抗結核薬を受けている219人の患者さんを対象とした.
- 肝機能検査は,治療開始時,4週目と8週目で行われました.
- 肝臓の異常やウイルス性肝炎を患っている患者は除外された.
主要な成果:
- ATDILIの罹患率は16. 0% (219人のうち35人) であった.
- 重度のATDILIは,影響を受けた患者の5. 7%で発生しました.
- 重要な予測要因には,女性の性別 (AOR=2. 57),高齢者 (AOR=1. 05),低体量指数 (AOR=0. 81) およびHIV陽性 (AOR=6. 73) が含まれていた.
結論:
- 中央エチオピアのホサナ市では,ATDILIの罹患率がかなり高い.
- 女性,高齢者,体重不足,HIV陽性結核患者は,ATDILIのリスクが高い.
- 肝機能の定期的なモニタリングは,これらの高リスクグループにおいて,ATDILIを緩和するために極めて重要です.
さらに関連する動画
関連する概念動画
Pulmonary Tuberculosis V
238
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
238
Pulmonary Tuberculosis I
324
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
Pulmonary Tuberculosis IV
204
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
204
Pulmonary Tuberculosis III
442
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
442
Pulmonary Tuberculosis II
345
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
345


